.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Oral Presentation
OP-25

The impact of thermal dose on pathological complete response in locally advanced rectal cancer patients treated with deep regional hyperthermia combined with neoadjuvant chemoradiotherapy: A multi-institutional propensity score matched analysis

Appointment

Date: 07/11/2024

Time: 16:05 – 16:17

Talk time: 9 Min.

Discussion time: 3 Min.

Location / Stream:

Auditorium (Aula magna)

Session

Clinical applications: Radio-chemo-immunotherapy

Topic

Hyperthermia clinical applications: radio-chemo-immunotherapy

Authors

Dr. Adela Ademaj (Aarau / CH; Zürich / CH), Prof. Dr. Oliver J. Ott (Erlangen / DE), Prof. Cihani Gani (Tübingen / DE), Prof. Olav Dahl (Bergen / NO), Dr. Emsad Puric (Aarau / CH), Dr. Benjamin Frey (Erlangen / DE), Dr. Manfred Schmidt (Erlangen / DE), Dietmar Marder (Aarau / CH), Dr. Roger A. Hälg (Aarau / CH; Zürich / CH), Dr. Johannes Crezee (Amsterdam / NL), Prof. Dr. Rainer Fietkau (Erlangen / DE), Prof. Dr. Oliver Riesterer (Aarau / CH)